Header image
This product is not currently available
CAR T-Cell Therapy for Multiple Myeloma


This is a virtual event, accessible online and over the phone. Access instructions will be provided after registration.


Join us for a FREE webinar designed to meet the educational
needs of multiple myeloma patients and their caregivers.

The most exciting area of myeloma research is chimeric antigen receptor (CAR) T-cell therapy, which uses a patient’s immune system to fight myeloma. CAR T technology involves extracting a patient’s white blood cells, modifying them in the lab so that they can recognize multiple myeloma, and re-infusing them to the patient. In clinical trials this approach has shown encouraging responses—yet this therapy can be toxic, and its availability to patients is still limited.

We invite you to join us for this webinar to learn about the promise and the challenges of CAR T-cell therapy. This webinar takes a look at some of the different types of CAR T cells and discusses how they have performed in clinical trials. Myeloma patients and their caregivers are sure to find this information helpful as they make future treatment decisions with their care team.

There is no fee for participating in this webinar. To register, add this event to your cart and complete the required information on the checkout page.


If you are unable to register online or do not receive a confirmation email after registering (don't forget to check your spam folder), please contact our Registration Desk at 866-872-5840 (international callers please dial 617-502-2061). You can also contact us by ✉ email



*Before you join us for the webinar(s), please provide us your responses to the following items.

*How much do you agree with the following statements?
(1 = Strongly disagree; 5 = Strongly agree)